BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/20/2021 12:49:51 PM | Browse: 387 | Download: 920
 |
Received |
|
2020-09-21 05:56 |
|
Peer-Review Started |
|
2020-09-21 05:56 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-11-16 21:41 |
|
Revised |
|
2020-11-25 22:16 |
|
Second Decision |
|
2021-01-27 06:37 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-03-08 03:38 |
|
Articles in Press |
|
2021-03-08 03:38 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-03-22 22:19 |
|
Typeset the Manuscript |
|
2021-04-15 01:31 |
|
Publish the Manuscript Online |
|
2021-04-20 12:49 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Positron emission tomography complete metabolic response as a favorable prognostic predictor in esophageal cancer following neo-adjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kosuke Suzuki, Tsuyoshi Etoh, Tomotaka Shibata, Kohei Nishiki, Shoichi Fumoto, Yoshitake Ueda, Hidefumi Shiroshita, Norio Shiraishi and Masafumi Inomata |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Kosuke Suzuki, PhD, Assistant Professor, Department of Gastroenterological and Pediatric Surgery, Oita University, 1-1 Idaigaoka, Hasama, Yufu 879-5593, Oita, Japan. kosuzuki@oita-u.ac.jp |
| Key Words |
Esophageal cancer; Neoadjuvant chemotherapy; Positron emission tomography/computed tomography; Complete metabolic response; Prognostic factor; Docetaxel, cisplatin plus 5-FU |
| Core Tip |
The study aimed to evaluate the value of Positron emission tomography (PET)/computed tomography complete metabolic response (CMR) as a prognostic predictor for esophageal cancer. Fifty-eight patients with esophageal cancer who underwent neoadjuvant chemotherapy in Oita University were enrolled. The PET-CMR group included 22 patients, and the Non-PET-CMR group included 36 patients. Five-year relapse-free survival (RFS) and overall survival in the PET-CMR group were significantly more favorable than those in the Non-PET-CMR group. PET-CMR was a significant prognostic factor in terms of RFS by univariate analysis. PET-CMR after neoadjuvant chemotherapy is considered a favorable prognostic factor for RFS in patients with esophageal cancer. |
| Publish Date |
2021-04-20 12:49 |
| Citation |
Suzuki K, Etoh T, Shibata T, Nishiki K, Fumoto S, Ueda Y, Shiroshita H, Shiraishi N, Inomata M. Positron emission tomography complete metabolic response as a favorable prognostic predictor in esophageal cancer following neo-adjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil. World J Clin Oncol 2021; 12(4): 249-261 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i4/249.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i4.249 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
